Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)

PURPOSE: Conventional staging methods are inadequate to identify patients with stage II colon cancer (CC) who are at high risk of recurrence after surgery with curative intent. ColDx is a gene expression, microarray-based assay shown to be independently prognostic for recurrence-free interval (RFI)...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Niedzwiecki, Donna, Frankel, Wendy L., Venook, Alan P., Ye, Xing, Friedman, Paula N., Goldberg, Richard M., Mayer, Robert J., Colacchio, Thomas Anthony, Mulligan, Jude Marie, Davison, Timothy S., O’Brien, Eamonn, Kerr, Peter, Johnston, Patrick G., Kennedy, Richard D., Harkin, D. Paul, Schilsky, Richard L., Bertagnolli, Monica M., Warren, Robert S., Innocenti, Federico
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2016
Subjects:
ORIGINAL REPORTS
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5012711/
https://ncbi.nlm.nih.gov/pubmed/27432924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.65.4699
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items